A Project Report on INDUSTRIAL VISIT (VIRTUAL)

Under the Subject BUSINESS EXPOSURE (19BaBiBu507)

Name of Student: Vedant S Pawar.

Class: TY BBA (IB)
Academic Year: 2021-2022

Submitted to:

Progressive Education Society's

Modern College of Arts, Science and Commerce
(Autonomous) Business Administration Campus
Shivajinagar, Pune - 411005.

In the partial fulfilment of Bachelor of Business Administration

(International Business)

Under the Guidance of: Prof. Manoj Yawalkar.

 Progressive Education Society's
Modern College of Arts, Science and Commerce
(Autonomous) Business Administration Campus
Shivajinagar, Pune - 411005.

Date:

CERTIFICATE

This is to certify that Vedant S Pawar of TY BBA IB has successfully completed the
project of BUSINESS EXPOSURE under my supervision and guidance towards partial
fulfilment of Bachelor of Business Administration (International Business) degree of
Modern College of Arts, Science and Commerce (Autonomous), Shivaji Nagar, Pune.

Project Guidance: Manoj Yawalkar.

[Internal Examiner] [External Examiner]

Prof. Dr. M. D. Alandikar Prof. Dr. Neha Dixit

(Vice Principal) HOD. BBA (IB)
 DECLARATION

I, Mr/Ms. Vedant S Pawar, student of TY BBA IB hereby declares

that this project report on the industrial visit conducted under the
subject BUSINESS EXPOSURE (19BaBiBu507) is my original
work.

The information and date given in this report is authentic to the best of
my knowledge.

Name: Vedant S Pawar

Class: TY BBA IB
Enrolment Number: 8735
Place: Pune
Date:

Signature
 ACKNOWLEDGEMENT

I, Vedant S Pawar, place on the records with great pleasure and express my profound
sense and sincere and deep gratitude to the help and encouragement for those who
are responsible for fetching us explore depth and provide with the foundation of
valuable knowledge and in experience that I have gained in the completion of those
felicitation project.

I express my deep gratitude to Prof. Manoj Yawalkar for extending his help and
guidance to us. Also, as well to all the other faculty members of our college for
providing inspiration throughout the project work.

I am thankful to our Vice Principal of Arts, Science, & Commerce (Business

Administration Campus), Prof. Dr. M. D. Alandikar for extending his support
towards the industrial visit and the project.

My deep sense of gratitude towards Prof. Neha Dixit, head of BBA IB department
for her support.

Thanks to everyone who has directly or indirectly helped me in the completion of this
project.

Name of Student: Vedant S Pawar

TY BBA- IB
 INDEX

Serial No. Name of the Company Page No.

1. Executive Summary

2. Objectives of Industrial Visit

4. SERUM INSTITUE OF INDIA

(VIRTUAL INDUTRIAL VISIT)

5. Learning & finding

6. Conclusion

7. Question & Answers (FAQ)

 EXECUTIVE SUMMARY

Industrial exposure is required for management students. Exposure in different

activities that is conducted in the industry. gives you an idea about how things
work in real life & you get to apply the theoretical part of your academics.

This visit has discussed about the realistic approach towards the management such
as how they plan operations, promotions, staffing, financing, productions.

What I have acquired from this visit are the manufacturing process and product
management

My report is largely based on manufacturing and production and processing

department which includes understanding the day-day operations, the machineries
and infrastructure.

This virtual visit has enlightened me about the insights of industries, functioning
and objectives.
SERUM INSTITUTE OF INDIA
INTRODUCTION
Serum Institute of India Pvt. Ltd. is now the world's largest vaccine
manufacturer by number of doses produced and sold globally (more
than 1.5 billion doses) which includes Polio vaccine as well as
Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles,
Mumps and Rubella vaccines. It is estimated that about 65% of the
children in the world receive at least one vaccine manufactured by
Serum Institute. Vaccines manufactured by the Serum Institute are
accredited by the World Health Organization, Geneva and are being
used in around 170 countries across the globe in their national
immunization programs, saving millions of lives throughout the world.
Serum Institute of India is ranked as India's No. 1 biotechnology
company, manufacturing highly specialized life saving biologicals like
vaccines using cutting edge genetic and cell based technologies,
antisera and other medical specialties.
Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla
with the aim of manufacturing life-saving immuno-biologicals, which
were in shortage in the country and imported at high prices.
Thereafter, several life-saving biologicals were manufactured at prices
affordable to the common man and in abundance, with the result that
the country was made self-sufficient for Tetanus Anti-toxin and Anti-
snake Venom serum, followed by DTP (Diphtheria, Tetanus and
Pertussis) group of Vaccines and then later on MMR (Measles,
Mumps and Rubella) group of vaccines.
The Philanthropic philosophy of the company still not only exists but
has been proliferated to bring down the prices of newer vaccines such
as Hepatitis-B vaccine, Combination vaccine etc., so that not only
Indian's, but the entire under-privileged children of the world are
protected from birth onwards.
 

A path-breaking acquisition - Bilthoven Biologicals, Netherlands

Serum Institute of India made its first International acquisition by

acquiring Bilthoven Biologicals, a bioengineering and pharmaceutical
company from The Netherlands Government on 29th June 2012. The
takeover ensures access to technology and expertise for making the
IPV (Injectable Polio Vaccine, Salk), earlier possessed by only 3 other
vaccine manufacturers. Bilthoven Biologicals is spread over 40 acres
with an installed manufacturing capacity of over 20 million doses of
vaccines annually. The production facilities are State-of-art and fully
compliant with cGMP and biopharmaceutical requirements.
The acquisition enhances Serum Institute's offerings in the pediatric
vaccine segment and with this Serum Institute hopes to make a
significant contribution to the eradication of Polio from the World.
The takeover also provides an important manufacturing base in
Europe, with access to strategic European Markets.
  A pathbreaking acquisition - Bilthoven Biologicals, Netherlands

WORLD CLASS PRODUCTION FACILITIES

Producing over a billion doses of quality vaccines

Serum Institute of India has established the most modern laboratories

with high-tech machinery and computerized equipment for the
production and testing of its life saving biologicals. Serum Institute's
commitment to global health is exemplified by significant investments
in its infrastructure. The production facilities are continuously
upgraded to ensure compliance with cGMP regulations and have been
accredited by the World Health Organization, Geneva.
Serum Institute of India has crossed many milestones in technological
advancement by installing robotic arm for virus handling, cell factory
and cell cube for growing cells, facilities for the manufacture of
polysaccharide and recombinant vaccines and for monoclonal
antibodies.
Sophisticated tunnel systems, high speed vial washing, filling,
stoppering and sealing machines are capable of working at a speed of
500 containers per minute and have been installed with filling
accuracy to the third digit of decimal point to ensure accuracy and
consistency.

Serum Institute of India has the latest technology screeners to inspect

its products for any minute particulate matter undetectable to the
normal human eye. Configured with high resolution CCD cameras and
electronic controlled panel, the inspection is done fully automatically,
thus reducing the margins of human errors.
With the licensure of additional facilities, Serum Institute of India has
the flexibility to produce vaccines in more than one plant, thus
facilitating production of large number of doses in the shortest time
frame. This enables the Institute to improve the response time to cater
to any international emergency or outbreak.

 Vaccine Manufacturing

COMMITMENT TO QUALITY
Serum Institute's quality control laboratories are equipped with a wide
array of sophisticated analytical equipment such as HPLC with PDA
detector, Fourier Transform Infra-Red Spectrophotometer, Gas
Chromatograph, Atomic Absorption Spectrophotometer, real-time
PCR, new Dionex, Karl Fischer Moisture Analyzer, ELISA Readers,
Liquid Particle Counters, Capillary Zone Electrophoresis, Bio-Plex
and several other state-of-the-art instruments. The technical team has
developed systems to ensure that quality is built into the process,
leading to consistency of output.
Periodical inspections of our facilities and product approvals obtained
from the World Health Organization and from national as well as
international regulatory authorities stand as testimony of Serum
Institute's commitment to quality.
 

POONAWALLA BIO-TECHNOLOGY PARK

The Poonawalla Bio-Tech Park at Manjari in Pune is a spread over a
sprawling area of 42 acres. This State-of-the-Art facility is designed to
meet the highest standards set by a plethora of regulatory agencies
includingthe MHRA, US-FDA and those of Europe, Japan, Australia
etc. To begin with products like HPV, TdaP, Monoclonal
Antibodies/Biosimilars, Rotavirus vaccine and recombinant BCG
vaccine will be manufactured here using the latest technology.
 

Bio-technology Park
CEO of SERUM Institute of India

Poonawalla joined the Serum

Institute of India in 2001 after
graduating from university.
Then exporting its
products to 35 countries,
Poonawalla concentrated on the
company's international market,
new products license
and getting pre-qualified by the World Health Organization for
supply to United Nations Agencies
including UNICEF and PAHO. As of 2015, he has helped the
company export its products to over 140 countries; 85 percent
of its revenues are from overseas.[5][6]
In 2011, he became the CEO. In 2012, he played a major role in
the acquisition of Bilthoven Biologicals, a Netherlands-based
government vaccine manufacturing company.[7][8] Poonawalla is
a board member of the GAVI Alliance, the global vaccine
alliance.[9]
He initiated and launched in 2014; Serum Institute's oral polio
vaccine, which became a bestseller for the company. It was
reported that he planned to expand the product portfolio to
include vaccines for dengue, flu and cervical cancer during the
same year.[6] Presently he is the CEO of Serum Institute of India.
On the 31st of May 2021, he was appointed as the chairman
of Magma Fincorp, after acquiring a 66% stake in the financial
services company.
 Cyrus S.
Poonawalla (born
in 1941) is an
Indian billionaire
businessman, and
the chairman and
managing director
of the Cyrus Poonawalla Group, which includes
the Serum Institute of India, an
Indian biotech company which is the
largest vaccine manufacturer in the world.[2][3] In
2021, he was ranked number 5 on Fortunes' India
rich list with a net worth of $19 billion.
Poonwalla founded the Serum Institute of India in
1966 and built it to the largest vaccine manufacturer
(by doses) in the world. Serum produces over 1.5
billion doses annually of a range of vaccines,
including for measles, polio and flu.
 PRODUCTS SUPPLIED IN INDIA
Bacterial Vaccines
Tubervac
Bacillus Calmette-Guerin (BCG) Vaccine I.P.
Tetanus Vaccine
Tetanus Vaccine (Adsorbed) I.P.
Dual Antigen
Diphtheria and Tetanus Vaccine (Adsorbed) I.P.
Triple Antigen
Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) I.P.
Sii Td-Vac
Diphtheria and Tetanus Vaccine (Adsorbed) for Adults and Adolescents I.P.
Viral Vaccines
Rabivax-S
Rabies Vaccine, Human I.P. (Freeze-dried)
M-Vac
Measles Vaccine (Live) I.P. (Freeze-dried)
Tresivac
Measles, Mumps and Rubella Vaccine (Live) I.P. (Freeze-dried)
MR-Vac
Measles & Rubella Vaccine (Live) I.P.
R-Vac
Rubella Vaccine (Live) I.P. (Freeze-dried)
Poliovac PFS/SD
Poliomyelitis Vaccine (Inactivated) I.P.
Rotasiil
Rotavirus Vaccine (Live Attenuated Oral) I.P. (Freeze-Dried)
Rotasiil Liquid
Rotavirus Vaccine (Live Attenuated Oral) I.P. (Oral)
Combination Vaccines
Pentavac SD/PFS
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus Type b Conjugate Vaccine (Adsorbed) I.P.
QUADROVAX SD/PFS (liquid)
Diphtheria, Tetanus, Pertussis (Whole Cell) and Haemophilus Type b Conjugate Vaccine (Adsorbed) I.P.
Recombinant and other Products
GeneVac-B
Hepatitis B Vaccine (rDNA) I.P.
Rabishield
Rabies Human Monoclonal antibody
Repoitin (Vial)
Recombinant Human Erythropoietin (rHuEPO) Injection 2000 IU, 4000 IU, 5000 IU and 10,000 IU
Repoitin (PFS)
Recombinant Human Erythropoietin (rHuEPO) Injection
Onco - BCG
Bacillus Calmette-Guerin (BCG) vaccine 40 mg
Imported Gonadotrophins Marketed in India
Sitrodin-HP
Highly Purified Urofollitrophin (FSH) for Inj. BP 75/150 IU
Persinal-HP
Highly Purified Menotrophin (HMG) for Inj. BP 75/150 IU
Sifasi-HP
Chorionic Gonadotropin Inj. I.P. 2000/5000/10000 IU
Indian Gonadotrophins
Sitrodin
Urofollitrophin for Injection BP 75/150 IU (Highly Purified)
Persinal
Menotrophin for Injection BP 75/150 IU (Highly Purified)
Sifasi
Chorionic Gonadotrophin Injection I.P. 2000/5000/10000 IU (Highly Purified)
Coronavirus disease (COVID-19) Vaccines
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant)
COVISHIELD™
Polysaccharide Conjugate Vaccines
Pneumosil (10-Valent with 6A & 19A)
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
1 dose, 5 dose
Pharma Products
Sii Somastin 250 and 3000
Somatostatin injection 250 mcg and 3 mg (Freeze - Dried)
SN-15 Tablets
Serratiopeptidase 15 mg and Nimesulide 100 mg tablets
SN-15 Plus
Serratiopeptidase and Diclofenac Potassium tablets
Limarin capsules and suspension
(Silymarin capsules and suspension)
Simrose and Simrose-1000
Evening Primrose Oil capsules
Pyginal
Pygeum africanum capsules
Dipep Capsules
Digestive enzyme preparations
Hemsi Capsules, syrup and Hemsi-PD drops
Haematinics
Logi-Cal-500
Calcium supplements
Sinate, Sinate-OD
Doxylamine succinate, Pyridoxine and Folic acid tablets
Mefanorm
Mefenamic acid suspension 100 mg/5 ml
Mefanorm Plus
Mefenanic acid 50 mg and Paracetamol 125 mg/5ml suspension
Mintonia
Zinc acetate syrup 20 mg/5 ml
Lacfid Capsules & Sachets
Probiotic combination
KQ-100
Ubidecarenone, L-Arginine, L-Carnitine, Piperine, Omega-3 Fatty Acids, Lycopene, Carotenoids and Minerals capsules
KQ-300
Ubidecarenone USP (Coenzyme Q10) 300 mg
I-KEY 100 Injections
Iron sucrose injections
I-KEY Nefro
Iron sucrose injections
Revter
Terlipressin Injection
Sii Evatone-2
Estradiol valerate tablets
Siphene 50 mg, Siphene-100, Siphene-M 25 mg
Clomiphene citrate tablets I.P.
Sicriptin 2.5 mg, Sicriptin 1.25 mg
Bromocriptine mesylate tablets I.P.
CB-Lin 0.5 mg, CB-Lin 0.25 mg
Cabergoline tablets USP
Zendol 50 mg, 100 mg, 200 mg

PRODUCTS
❖ Learning & finding

1.Industrial visits! The term itself instils immense happiness and excitement in
students. The idea of embarking on an educational trip encourages many.
However, for some, this excitement is soon killed when they are not allowed to go
for the industrial visit. Because of monetary and family reasons, students often
avoid these visits. It is high time that you realise the importance of these visits and
take them as an opportunity to learn about your dream career.

1]Industrial visits offer a great source to gain practical knowledge. Students

can observe and learn as to how theatrical concepts are put to into action,
thereby aiding their practical learning. Students are exposed to real working
environment and shown how things are done in an organisation. From the
details about the management to the targets they achieve, everything is covered
in these visits.

2]Industrial visits are a complete package which aims at widening the

knowledge of students. It is not just an outing organised by school/college
authorities for fun. These visits are related to your curriculum, so you get to
learn things which are beneficial to you in the future. They are totally
educational in nature with rich learning experience.

3]Also, students are always curious about what kind of work they would be
doing after entering their favourite industry. Through industrial visits, they can
clarify their doubts and silence their curiosities. They can communicate with
people and organisations to get a clear idea of their dream job.

4]The gap between theoretical learning and practical exposure is actually

bridged by industrial visits. The importance of industrial visits is such that it
has been made mandatory in many institutions.
 ❖ Conclusion:-

1] The company exports the products outside the country.

2] Most of the export products are of India itself.

3] SERUM INSTITUTE OF INDIA products and services are best

all over India.

4] Supply chain management and marketing strategies are best.

 FAQs

1. What kind of vaccine is COVISHIELDTM?

It is a recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike (S)
glycoprotein. Following administration, the genetic material of part of corona virus is expressed which
stimulates an immune response.

2. What excipients are present in COVISHIELDTM?

COVISHIELDTM contains the following excipients:

 L-Histidine
 L-Histidine hydrochloride monohydrate
 Magnesium chloride hexahydrate
 Polysorbate 80
 Ethanol
 Sucrose
 Sodium chloridessssss
 Disodium edetate dihydrate (EDTA)

3. COVISHIELDTM regimen consists of how many doses?

It consists of two doses of 0.5 ml each.

4. Is there any difference between 1st and 2nd dose?

No. There is no difference between the 1st and 2nd dose. Each dose has the same content of viral particles.

5. Do I require any test (e.g. CRP, BTCT, RTPCR etc.) before getting the vaccine?
No. There are no such recommendations.